Numerate Awarded U.S. Department of Defense Contract to Extend Drug Design Platform

Published: Sep 09, 2010

SAN BRUNO, Calif.--(BUSINESS WIRE)--Numerate, Inc. announced today that it has been awarded a new three-year contract by the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense, to adapt its pioneering small-molecule drug design platform to the rapid design and optimization of drugs against biowarfare agents.

Back to news